Reversible Acylation of Factor Xa as a Potential Therapy for Hemophilia

Author： Lin P.H. Laibelman A.M. Sinha U.

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.88, Iss.4, 1997-11, pp. : 365-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin-Binding Exosite of Factor Xa

By Rezaie A.R.

Trends in Cardiovascular Medicine, Vol. 10, Iss. 8, 2000-11 ,pp. : 333-338

Elsevier

Access to resources Recommend Favorite

Synthetic direct and indirect factor Xa inhibitors

By Samama M.M.

Thrombosis Research, Vol. 106, Iss. 3, 2002-05 ,pp. : 267-273

Elsevier

Access to resources Recommend Favorite

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

By Becker Richard

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 183-187

Springer Publishing Company

Access to resources Recommend Favorite

Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor

By Hara T. Yokoyama A. Morishima Y. Kunitada S.

Thrombosis Research, Vol. 80, Iss. 1, 1995-10 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

The Importance of Factor Xa Regulatory Pathways in Vascular Thromboresistance: Focus on Protein Z

By Becker Richard

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 2, 2005-04 ,pp. : 135-137

Springer Publishing Company

Access to resources Recommend Favorite